Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

E Laille, M Patel, SF Jones, HA Burris III… - The Journal of …, 2015 - Wiley Online Library
Two multicenter, single‐arm, single‐infusion, open‐label studies were conducted to
evaluate the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A …
被引用次数：12 相关文章

[引用][C] Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

E Laille, M Patel, SF Jones, HA Burris… - The Journal of Clinical …, 2015 - cir.nii.ac.jp
Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with
advanced cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ …
[PDF] cyberleninka.org

[PDF][PDF] Evaluation of CYP3A-Mediated Drug–Drug Interactions With Romidepsin in Patients With Advanced Cancer

MS Eric Laille, MD Manish Patel… - The Journal of …, 2015 - cyberleninka.org
Two multicenter, single-arm, single-infusion, open-label studies were conducted to evaluate
the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A inducer) …

Evaluation of CYP3A-Mediated Drug-Drug Interactions With Romidepsin in Patients With Advanced Cancer.

E Laille, M Patel, SF Jones, HA Burris… - Journal of Clinical …, 2015 - search.ebscohost.com
Two multicenter, single-arm, single-infusion, open-label studies were conducted to evaluate
the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A inducer) …

Evaluation of CYP3A-mediated drug-drug interactions with romidepsin in patients with advanced cancer

E Laille, M Patel, SF Jones… - Journal of clinical …, 2015 - pubmed.ncbi.nlm.nih.gov
Two multicenter, single-arm, single-infusion, open-label studies were conducted to evaluate
the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A inducer) …
[PDF] scienceopen.com

[PDF][PDF] Evaluation of CYP3A-Mediated Drug–Drug Interactions With Romidepsin in Patients With Advanced Cancer

MS Eric Laille, MD Manish Patel… - The Journal of …, 2015 - scienceopen.com
Two multicenter, single-arm, single-infusion, open-label studies were conducted to evaluate
the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A inducer) …
[HTML] nih.gov

[HTML][HTML] Evaluation of CYP3A‐mediated drug–drug interactions with romidepsin in patients with advanced cancer

E Laille, M Patel, SF Jones, HA Burris III… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Two multicenter, single‐arm, single‐infusion, open‐label studies were conducted to
evaluate the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A …

Evaluation of CYP3A-mediated drug-drug interactions with romidepsin in patients with advanced cancer.

E Laille, M Patel, SF Jones, HA Burris 3rd… - Journal of Clinical …, 2015 - europepmc.org
Two multicenter, single‐arm, single‐infusion, open‐label studies were conducted to
evaluate the effect of ketoconazole (a strong CYP3A inhibitor) or rifampin (a strong CYP3A …